Semin Thromb Hemost 2003; 29(2): 125-130
DOI: 10.1055/s-2003-38897
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Hemostasis during Normal Pregnancy and Puerperium

Margareta Hellgren
  • Assistant Professor, Department of Obstetrics and Gynecology, Göteborg University and Sahlgrenska University Hospital, Göteborg, Sweden
Further Information

Publication History

Publication Date:
23 April 2003 (online)

ABSTRACT

During normal pregnancy the hemostatic balance changes in the direction of hypercoagulability, thus decreasing bleeding complications in connection with delivery. The most important initial factor for acute hemostasis at delivery is, however, uterine muscle contractions, which interrupt blood flow. Global tests such as Sonoclot;rM signature, the Thromboelastogram;rM, and a new method analyzing overall plasma hemostasis, all show changes representative of hypercoagulability during pregnancy. Increased endogenous thrombin generation, acquired activated protein C resistance, slightly decreased activated partial thromboplastin time (aPTT) and increased prothrombin complex level (PT) measured as international normalized ratio (INR) of less than 0.9 have been reported as well. In normal pregnancy, the platelet count is within normal range except during the third trimester when benign gestational thrombocytopenia, 80 to 150 × 109/L, can be observed. Platelet turnover is usually normal. Activation of platelets and release of beta-thromboglobulin and platelet factor 4 are reported. The bleeding time is unchanged during normal pregnancy. Most blood coagulation factors and fibrinogen increase during pregnancy. Factor (F) XI is the only blood coagulation factor that decreases. Blood coagulation inhibitors are mainly unchanged but the level of free protein S decreases markedly and the level of tissue factor pathway inhibitor increases. Thrombomodulin levels increase during pregnancy. Fibrinolytic capacity is diminished during pregnancy, mainly because of markedly increased levels of plasminogen activator inhibitor-1 (PAI-1) from endothelial cells and plasminogen activator inhibitor-2 (PAI-2) from the placenta. Thrombin-activated fibrinolysis inhibitor is reported to be unaffected. The total hemostatic balance has been studied by analyses of prothrombin fragment 1+2, thrombin-antithrombin complex, fibrinopeptide A, soluble fibrin, D-dimer, and plasmin-antiplasmin complex. There is activation of blood coagulation and a simultaneous increase in fibrinolysis without signs of organ dysfunction during normal pregnancy. These changes increase as pregnancy progresses. During delivery, there is consumption of platelets and blood coagulation factors, including fibrinogen. Fibrinolysis improves and increases fast following childbirth and expulsion of the placenta, resulting in increased D-dimer levels. These changes are self-limiting at normal delivery. The hemostatic changes, noted during pregnancy, normalize after delivery within 4 to 6 weeks. Platelet count and free protein S, however, can be abnormal longer. Hemostasis should not be tested earlier than 3 months following delivery and after terminating lactation to rule out influences of pregnancy. PAI-1 and PAI-2 levels decrease fast postpartum, but PAI 2 has been detected up to 8 weeks postpartum. α2-antiplasmin, urokinase, and kallikrein inhibitor levels have been reported to be increased 6 weeks postpartum.

REFERENCES

  • 1 Sheppard B L, Bonnar J. Uteroplacental hemostasis in intrauterine fetal growth retardation.  Semin Thromb Hemost . 1999;  25 443-446
  • 2 Hett D A, Walker D, Pilkington S N, Smith D C. Sonoclot analysis.  Br J Anaesthesiol . 1995;  75 771-776
  • 3 Kjellberg U, Hellgren M. Sonoclot signature during normal pregnancy.  Intensive Care Med . 2000;  26 206-211
  • 4 Chandler W L. The thromboelastograph and the thromboelastograph technique.  Semin Thromb Hemost . 1995;  21 1-6
  • 5 Sharma S K, Philip J. The effect of anesthetic techniques on blood coagulability in parturients as measured by thromboelastography.  Anesth Analg . 1997;  85 82-86
  • 6 Sharma S K, Philip J, Whitten C W. et al . Assessment of changes in coagulation in parturients with preeclampsia using thrombelastography.  Anesthesiology . 1999;  90 385-390
  • 7 He S, Bremme K, Blombäck M. A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results.  Thromb Res . 1999;  96 145-156
  • 8 Hemker H C, Beguin S. Thrombin generation in plasma: its assessment via endogenous thrombin potential.  Thromb Haemost . 1995;  74 134-138
  • 9 Nicolaes G A, Thomassen M C, Tans G. et al . Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC resistant individuals.  Blood Coagul Fibrinolysis . 1997;  8 28-38
  • 10 Eichinger S, Weltermann A, Philipp K. et al . Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.  Thromb Haemost . 1999;  82 1232-1236
  • 11 Clark P, Brennand J, Conkie J A. et al . Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy.  Thromb Haemost . 1998;  79 1166-1170
  • 12 Cerneca F, Ricci G, Simeone R. et al . Coagulation and fibrinolysis changes in normal pregnancy, increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis.  Eur J Obstet Gynecol Reprod Biol . 1997;  73 31-36
  • 13 Berge L N, Lyngmo V, Svensson B, Nordoy A. The bleeding time in women: an influence of the sex hormones.  Acta Obstet Gynecol Scand . 1993;  72 423-427
  • 14 Rymark P, Berntorp E, Nordsjö P. et al . Low-dose aspirin to pregnant women: single dose pharmacokinetics and influence of short-term treatment on bleeding time.  J Perinat Med . 1994;  22 205-211
  • 15 Rakoczi I, Tallian F, Bagdany S, Gati I. Platelet life-span in normal pregnancy and preeclampsia as determined by a non-radioisotope technique.  Thromb Res . 1979;  15 553-556
  • 16 Pekonen F, Rasi V, Ämmälä M. et al . Platelet function in normal and preeclamptic pregnancy.  Thromb Res . 1986;  43 553-560
  • 17 Gatti L, Tenconi P M, Guarneri D. et al . Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy.  Int J Clin Lab Res . 1994;  24 217-219
  • 18 Howarth S, Marshall L R, Barr A L. et al . Platelet indices during normal pregnancy and preeclampsia.  Br J Biomed Sci . 1999;  56 20-22
  • 19 Hayashi M, Kuimi F, Mitsuya K. Changes in platelet ATP secretion and aggregation during pregnancy and in preeclampsia.  Am J Med Sci . 1999;  318 115-121
  • 20 Aster R H. Gestational thrombocytopenia. A plea for conservative management.  N Engl J Med . 1990;  323 264-266
  • 21 Burrows R F, Kelton J G. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries.  Am J Obstet Gynecol . 1990;  162 731-734
  • 22 Louden K A, Broughton Pipkin F, Heptinstall S. et al . A longitudinal study of platelet behaviour and thromboxane production in whole blood in normal pregnancy and the puerperium.  Br J Obstet Gynecol . 1990;  97 1108-1114
  • 23 Nicolini U, Guarneri D, Gianotti G A. et al . Maternal and fetal platelet activation in normal pregnancy.  Obstet Gynecol . 1994;  83 65-69
  • 24 Konijnenberg A, Stokkers E W, van der Post A M J. et al . Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.  Am J Obstet Gynecol . 1997;  176 461-469
  • 25 Star J, Rosene K, Ferland J. et al . Flow cytometric analysis of platelet activation throughout normal gestation.  Obstet Gynecol . 1997;  90 562-568
  • 26 Douglas J T, Shah M, Lowe G D. et al . Plasma fibrinopeptide A and beta-thromboglobulin in preeclampsia and pregnancy hypertension.  Thromb Haemost . 1982;  1 54-55
  • 27 Romero R, Snyder E, Scott D. et al . Beta-thromboglobulin during normal pregnancy, labour and puerperium.  Am J Perinatol . 1988;  5 109-112
  • 28 Ayhan A, Akkok E, Urman B. et al . Beta-thromboglobulin and platelet factor 4 levels in pregnancy and preeclampsia.  Gynecol Obstet Invest . 1990;  30 12-14
  • 29 Hellgren M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium.  Gynecol Obstet Invest . 1981;  12 141-154
  • 30 Kjellberg U, Andersson N-E, Rosén S. et al . APC resistance and other haemostatic variables during pregnancy and puerperium.  Thromb Haemost . 1999;  81 527-531
  • 31 Sattar N, Greer I A, Rumley A. et al . A longitudinal study of the relationships between haemostatic, lipid and oestradiol changes during normal human pregnancy.  Thromb Haemost . 1999;  81 71-75
  • 32 Bellart J, Gilabert R, Fontcuberta J. et al . Coagulation and fibrinolysis in normal pregnancy and in gestational diabetes.  Am J Perinatol . 1998;  15 479-486
  • 33 Bremme K, Östlund E, Almquist I. et al . Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium.  Obstet Gynecol . 1992;  80 132-137
  • 34 She H, Wramsby M, Bokarewa M. et al . Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy.  J Thromb Thrombolysis . 2000;  9 277-281
  • 35 Sandset P M, Hellgren M, Uvebrandt M, Bergström H. Extrinsic coagulation pathway inhibitor and heparin co-factor II during normal and hypertensive pregnancy.  Thromb Res . 1989;  55 665-670
  • 36 de Moerloose P, Mermillod N, Amiral J, Reber G. Thrombomodulin levels during normal pregnancy, at delivery and the postpartum: comparison with tissue-type activator and plasminogen activator inhibitor-1.  Thromb Haemost . 1998;  79 554-556
  • 37 Nakashima A, Kobayashi T, Terao T. Fibrinolysis during normal pregnancy and severe preeclampsia; relationships between plasma levels of plasminogen activators and inhibitors.  Gynecol Obstet Invest . 1996;  42 95-101
  • 38 Bellart J, Gilabert R, Fontcuberta J. et al . Fibrinolysis changes in normal pregnancy.  J Perinat Med . 1997;  25 368-372
  • 39 Chetaille P, Alessi M C, Kouassi D. et al . Plasma TAFI antigen variations in healthy subjects.  Thromb Haemost . 2000;  83 902-905
  • 40 Bellart J, Gilabert R, Miralles R M. et al . Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy.  Gynecol Obstet Invest . 1998;  46 17-21
  • 41 Andersson T, Lorentzen B, Högdahl H. et al . Thrombin-inhibitor complexes in the blood during and after delivery.  Thromb Res . 1996;  82 109-117
  • 42 Montes R, Paramo J A, Angles-Cano E, Rocha E. Development and clinical application of a new ELISA assay to determine plasmin-alfa-antiplasmin complexes in plasma.  Br J Haematol . 1996;  92 979-985
  • 43 Dahlman T, Hellgren M, Blombäck M. Changes in blood coagulation and fibrinolysis in the normal puerperium.  Gynecol Obstet Invest . 1985;  20 37-44
    >